Valute / ANAB
ANAB: AnaptysBio Inc
20.33
USD
0.20
(0.99%)
Il tasso di cambio ANAB ha avuto una variazione del 0.99% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 19.85 e ad un massimo di 20.50.
Segui le dinamiche di AnaptysBio Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
ANAB News
- AnaptysBio earnings beat by $0.18, revenue topped estimates
- AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates
- AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
- Connect Biopharma appoints James A. Schoeneck to board of directors
- AnaptysBio: Potential Promise, But Some Cause For Skepticism (NASDAQ:ANAB)
- Anaptysbio director Fenton sells $72k in stock
- AnaptysBio: Rosnilimab's RA Data Sets The Stage For Blockbuster Potential (NASDAQ:ANAB)
- AnaptysBio: Positive RA Data Bodes Well For Continued Rosnilimab Advancement (NASDAQ:ANAB)
- AnaptysBio Upgraded After RA Drug Matches Top Therapies In Phase 2 Trial - AnaptysBio (NASDAQ:ANAB)
- Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May - AnaptysBio (NASDAQ:ANAB), Asana (NYSE:ASAN)
- This Snowflake Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - AnaptysBio (NASDAQ:ANAB), Blueprint Medicines (NASDAQ:BPMC)
- Stifel analysts reiterate Buy rating for AnaptysBio stock after RA study
- TD Cowen reiterates Buy rating on AnaptysBio stock following updated trial data
- H.C. Wainwright upgrades AnaptysBio stock on positive trial data
- AnaptysBio reports promising Phase 2b trial results for RA drug
- What’s the role of generative AI in drug discovery?
- Market Cap Stock Movers Dominate Wednesday Trading Session
- Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday - AnaptysBio (NASDAQ:ANAB), Abercrombie & Fitch (NYSE:ANF)
- Guggenheim raises AnaptysBio stock target to $90, maintains Buy
- Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
- Wolfe Research maintains Outperform on AnaptysBio shares, $25 target
- Crude Oil Gains 1%; US Composite PMI Surges In March - AnaptysBio (NASDAQ:ANAB), AZEK Co (NYSE:AZEK)
- Intuitive Machines Posts Q4 Results, Joins Tesla, AnaptysBio, Coherent And Other Big Stocks Moving Higher On Monday - AnaptysBio (NASDAQ:ANAB), AZEK Co (NYSE:AZEK)
- UiPath Posts Weak Revenue, Joins SentinelOne, American Eagle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - AnaptysBio (NASDAQ:ANAB), American Eagle Outfitters (NYSE:AEO)
Intervallo Giornaliero
19.85
20.50
Intervallo Annuale
12.22
40.70
- Chiusura Precedente
- 20.13
- Apertura
- 20.10
- Bid
- 20.33
- Ask
- 20.63
- Minimo
- 19.85
- Massimo
- 20.50
- Volume
- 1.088 K
- Variazione giornaliera
- 0.99%
- Variazione Mensile
- -16.82%
- Variazione Semestrale
- 20.15%
- Variazione Annuale
- -46.20%
31 agosto, domenica